82 related articles for article (PubMed ID: 11495498)
1. Probing the shape of a hydrophobic pocket in the active site of delta-opioid antagonists.
Santagada V; Caliendo G; Severino B; Perissutti E; Ceccarelli F; Giusti L; Mazzoni MR; Salvadori S; Temussi PA
J Pept Sci; 2001 Jul; 7(7):374-85. PubMed ID: 11495498
[TBL] [Abstract][Full Text] [Related]
2. Conformational analysis of potent and very selective delta opioid dipeptide antagonists.
Amodeo P; Balboni G; Crescenzi O; Guerrini R; Picone D; Salvadori S; Tancredi T; Temussi PA
FEBS Lett; 1995 Dec; 377(3):363-7. PubMed ID: 8549756
[TBL] [Abstract][Full Text] [Related]
3. Novel Dmt-Tic dipeptide analogues as selective delta-opioid receptor antagonists.
Pagé D; McClory A; Mischki T; Schmidt R; Butterworth J; St-Onge S; Labarre M; Payza K; Brown W
Bioorg Med Chem Lett; 2000 Jan; 10(2):167-70. PubMed ID: 10673103
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
5. Role of hydrophobic substituents in the interaction of opioid Tyr-Tic dipeptide analogs with dodecylphosphocholine micelles. Molecular partitioning in model membrane systems.
Carpenter KA; Wilkes BC; Weltrowska G; Schiller PW
Eur J Biochem; 1996 Nov; 241(3):756-64. PubMed ID: 8944763
[TBL] [Abstract][Full Text] [Related]
6. Opioid diketopiperazines: refinement of the delta opioid antagonist pharmacophore.
Bryant SD; Balboni G; Guerrini R; Salvadori S; Tomatis R; Lazarus LH
Biol Chem; 1997 Feb; 378(2):107-14. PubMed ID: 9088539
[TBL] [Abstract][Full Text] [Related]
7. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
Hosohata K; Varga EV; Alfaro-Lopez J; Tang X; Vanderah TW; Porreca F; Hruby VJ; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 2003 Feb; 304(2):683-8. PubMed ID: 12538822
[TBL] [Abstract][Full Text] [Related]
8. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2004 Jul; 47(16):4066-71. PubMed ID: 15267245
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of dipeptides containing the Dmt-Tic pharmacophore.
Bryant SD; George C; Flippen-Anderson JL; Deschamps JR; Salvadori S; Balboni G; Guerrini R; Lazarus LH
J Med Chem; 2002 Dec; 45(25):5506-13. PubMed ID: 12459018
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
Wilkes BC; Schiller PW
Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
[TBL] [Abstract][Full Text] [Related]
11. Selective opioid dipeptides.
Temussi PA; Salvadori S; Amodeo P; Bianchi C; Guerrini R; Tomatis R; Lazarus LH; Picone D; Tancredi T
Biochem Biophys Res Commun; 1994 Feb; 198(3):933-9. PubMed ID: 8117299
[TBL] [Abstract][Full Text] [Related]
12. Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogue.
Labarre M; Butterworth J; St-Onge S; Payza K; Schmidhammer H; Salvadori S; Balboni G; Guerrini R; Bryant SD; Lazarus LH
Eur J Pharmacol; 2000 Oct; 406(1):R1-3. PubMed ID: 11011049
[TBL] [Abstract][Full Text] [Related]
13. Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists.
Li T; Fujita Y; Shiotani K; Miyazaki A; Tsuda Y; Ambo A; Sasaki Y; Jinsmaa Y; Marczak E; Bryant SD; Salvadori S; Lazarus LH; Okada Y
J Med Chem; 2005 Dec; 48(25):8035-44. PubMed ID: 16335927
[TBL] [Abstract][Full Text] [Related]
14. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
[TBL] [Abstract][Full Text] [Related]
15. Conversion of enkephalin and dermorphin into delta-selective opioid antagonists by single-residue substitution.
Tancredi T; Salvadori S; Amodeo P; Picone D; Lazarus LH; Bryant SD; Guerrini R; Marzola G; Temussi PA
Eur J Biochem; 1994 Aug; 224(1):241-7. PubMed ID: 8076645
[TBL] [Abstract][Full Text] [Related]
16. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.
Wilkes BC; Schiller PW
Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733
[TBL] [Abstract][Full Text] [Related]
17. Solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid.
Ciajolo MR; Balboni G; Picone D; Salvadori S; Tancredi T; Temussi PA; Tuzi A
Int J Pept Protein Res; 1995 Aug; 46(2):134-8. PubMed ID: 8567167
[TBL] [Abstract][Full Text] [Related]
18. Selective delta-opioid receptor antagonist N,N(CH3)2-Dmt-Tic-OH does not reduce ethanol intake in alcohol-preferring AA rats.
Ingman K; Salvadori S; Lazarus L; Korpi ER; Honkanen A
Addict Biol; 2003 Jun; 8(2):173-9. PubMed ID: 12850776
[TBL] [Abstract][Full Text] [Related]
19. Dmt-Tic-OH a highly selective and potent delta-opioid dipeptide receptor antagonist after systemic administration in the mouse.
Capasso A; Guerrini R; Balboni G; Sorrentino L; Temussi P; Lazarus LH; Bryant SD; Salvadori S
Life Sci; 1996; 59(8):PL93-8. PubMed ID: 8761022
[TBL] [Abstract][Full Text] [Related]
20. Design of mu selective opioid dipeptide antagonists.
Capasso A; Amodeo P; Balboni G; Guerrini R; Lazarus LH; Temussi PA; Salvadori S
FEBS Lett; 1997 Nov; 417(1):141-4. PubMed ID: 9395092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]